PerspectiveNEURODEGENERATION

Alzheimer's disease: The right drug, the right time

See allHide authors and affiliations

Science  14 Dec 2018:
Vol. 362, Issue 6420, pp. 1250-1251
DOI: 10.1126/science.aau0437

Article Information

vol. 362 no. 6420 1250-1251

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. Todd E. Golde1,
  2. Steven T. DeKosky1,
  3. Douglas Galasko2
  1. 1Evelyn F. and William L. McKnight Brain Institute, Center for Translational Research in Neurodegenerative Disease, Departments of Neuroscience and Neurology, College of Medicine, University of Florida, Gainesville, FL, USA.
  2. 2Department of Neurosciences and Shiley-Marcos Alzheimer's Disease Research Center, University of California San Diego, La Jolla, CA, USA.
  1. Email: tgolde{at}ufl.edu; steven.dekosky{at}neurology.ufl.edu; dgalasko{at}ucsd.edu

Altmetric

Article usage

Article usage: December 2018 to October 2020

AbstractFullPdf
Dec 2018907161834102
Jan 2019967549435
Feb 2019328282150
Mar 2019329253137
Apr 201929118391
May 201929011368
Jun 20192867630
Jul 20191298747
Aug 20191199036
Sep 2019899347
Oct 201912612463
Nov 201911914675
Dec 20191309038
Jan 20201308734
Feb 202010010038
Mar 20201089347
Apr 20201679343
May 20201198825
Jun 20201107121
Jul 2020885517
Aug 2020676126
Sep 2020776928
Oct 2020494113

Stay Connected to Science